KITS — Kits Eyecare Income Statement
0.000.00%
- CA$370.35m
- CA$363.68m
- CA$159.34m
- 89
- 23
- 99
- 81
Annual income statement for Kits Eyecare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 75.2 | 82.4 | 91.6 | 121 | 159 |
Cost of Revenue | |||||
Gross Profit | 21.4 | 20.9 | 29.2 | 40.8 | 53.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 74.9 | 99.8 | 96 | 122 | 154 |
Operating Profit | 0.3 | -17.4 | -4.35 | -1.92 | 5.07 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.09 | -18.8 | -5.88 | -2.89 | 4.45 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.58 | -14.6 | -4.55 | -2.21 | 3.12 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.58 | -14.6 | -4.55 | -2.21 | 3.12 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -6.58 | -14.6 | -4.55 | -2.21 | 3.12 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.197 | -0.443 | -0.146 | -0.08 | 0.1 |
Dividends per Share |